Eltrombopag for the treatment of aplastic anemia: current perspectives

References

• MontanéEIbáñezLVidalXCatalan Group for Study of Agranulocytosis and Aplastic AnemiaEpidemiology of aplastic anemia: a prospective multicenter studyHaematologica200893451852318322256
   PubMed Web of Science ®Google Scholar
• YoungNSKaufmanDWThe epidemiology of acquired aplastic anemiaHaematologica200893448949218379007
   PubMed Web of Science ®Google Scholar
• KillickSBBownNCavenaghJBritish Society for Standards in HaematologyGuidelines for the diagnosis and management of adult aplastic anaemiaBr J Haematol2016172218720726568159
   PubMed Web of Science ®Google Scholar
• MarshJCBallSECavenaghJBritish Committee for Standards in HaematologyGuidelines for the diagnosis and management of aplastic anaemiaBr J Haematol20091471437019673883
   PubMed Web of Science ®Google Scholar
• MarshJCBallSEDarbyshirePBritish Committee for Standards in HaematologyGuidelines for the diagnosis and management of acquired aplastic anaemiaBr J Haematol2003123578280114632769
   PubMed Web of Science ®Google Scholar
• YoungNSCaladoRTScheinbergPCurrent concepts in the pathophysiology and treatment of aplastic anemiaBlood200610882509251916778145
   PubMed Web of Science ®Google Scholar
• YoungNSCurrent concepts in the pathophysiology and treatment of aplastic anemiaHematology Am Soc Hematol Educ Program20132013768124319166
   PubMed Web of Science ®Google Scholar
• XuJLNagasakaTNakashimaNInvolvement of cytotoxic granules in the apoptosis of aplastic anaemiaBr J Haematol2003120585085212614221
   PubMed Web of Science ®Google Scholar
• DaviesJKGuinanECAn update on the management of severe idiopathic aplastic anaemia in childrenBr J Haematol2007136454956417214739
   PubMed Web of Science ®Google Scholar
• DoneyKLeisenringWStorbRAppelbaumFRPrimary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle bone marrow transplant teamAnn Intern Med199712621071159005744
   PubMed Web of Science ®Google Scholar
• MyersKCDaviesSMHematopoietic stem cell transplantation for bone marrow failure syndromes in childrenBiol Blood Marrow Transplant200915327929219203719
   PubMed Web of Science ®Google Scholar
• ChamplinREPerezWSPasswegJRBone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensBlood2007109104582458517272503
   PubMed Web of Science ®Google Scholar
• KahlCLeisenringWDeegHJCyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-upBr J Haematol2005130574775116115132
   PubMed Web of Science ®Google Scholar
• LocatelliFBrunoBZeccaMCyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trialBlood20009651690169710961865
   PubMed Web of Science ®Google Scholar
• PasswegJRSociéGHinterbergerWBone marrow transplantation for severe aplastic anemia: has outcome improved?Blood19979028588649226187
   PubMed Web of Science ®Google Scholar
• DufourCVeysPCarraroESimilar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT working party, paediatric diseases working party and severe aplastic anaemia working party of EBMTBr J Haematol2015171458559426223288
   PubMed Web of Science ®Google Scholar
• SchrezenmeierHMarinPRaghavacharARelapse of aplastic anaemia after immunosuppressive treatment: a report from the European bone marrow transplantation group SAA working partyBr J Haematol19938523713778280610
   PubMed Web of Science ®Google Scholar
• BacigalupoABrunoBSaraccoPAntilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European group for blood and marrow transplantation (EBMT) working party on severe aplastic anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)Blood20009561931193410706857
   PubMed Web of Science ®Google Scholar
• TichelliASociéGHenry-AmarMEffectiveness of immunosuppressive therapy in older patients with aplastic anemia. European group for blood and marrow transplantation severe aplastic anaemia working partyAnn Intern Med1999130319320110049197
   PubMed Web of Science ®Google Scholar
• SociéGHenry-AmarMBacigalupoAMalignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic anaemia working partyN Engl J Med199332916115211578377778
   PubMed Web of Science ®Google Scholar
• FrickhofenNHeimpelHKaltwasserJPSchrezenmeierHGerman Aplastic Anemia Study GroupAntithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemiaBlood200310141236124212393680
   PubMed Web of Science ®Google Scholar
• KuterDJBeelerDLRosenbergRDThe purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet productionProc Natl Acad Sci U S A1994912311104111087972018
   PubMed Web of Science ®Google Scholar
• KatoTOgamiKShimadaYPurification and characterization of thrombopoietinJ Biochem199511812292368537317
   PubMed Web of Science ®Google Scholar
• FosterDCSprecherCAGrantFJHuman thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localizationProc Natl Acad Sci U S A1994912613023130277809166
   PubMed Web of Science ®Google Scholar
• GurneyALKuangWJXieMHMalloyBEEatonDLde SauvageFJGenomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietinBlood19958549819887849319
   PubMed Web of Science ®Google Scholar
• HitchcockISKaushanskyKThrombopoietin from beginning to endBr J Haematol2014165225926824499199
   PubMed Web of Science ®Google Scholar
• ZeiglerFCde SauvageFWidmerHRIn vitro megakaryocytopoietic and thrombopoietic activity of c-Mpl ligand (TPO) on purified murine hematopoietic stem cellsBlood19948412404540527527664
   PubMed Web of Science ®Google Scholar
• StasiREltrombopag: the discovery of a second generation thrombopoietin-receptor agonistExpert Opin Drug Discov200941859323480339
   PubMed Web of Science ®Google Scholar
• QianHBuza-VidasNHylandCDCritical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cellsCell Stem Cell20071667168418371408
   PubMed Web of Science ®Google Scholar
• YoshiharaHAraiFHosokawaKThrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic nicheCell Stem Cell20071668569718371409
   PubMed Web of Science ®Google Scholar
• MiyazakiHPhysiologic role of TPO in thrombopoiesisStem Cells199614suppl 113313811012213
   PubMedGoogle Scholar
• WalneAJDokalAPlagnolVExome sequencing identifies MPL as a causative gene in familial aplastic anemiaHaematologica201297452452822180433
   PubMed Web of Science ®Google Scholar
• GeddisAECongenital amegakaryocytic thrombocytopeniaPediatr Blood Cancer201157219920321337678
   PubMed Web of Science ®Google Scholar
• BallmaierMGermeshausenMCongenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatmentSemin Thromb Hemost201137667368122102270
   PubMed Web of Science ®Google Scholar
• KimuraSRobertsAWMetcalfDAlexanderWSHematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietinProc Natl Acad Sci U S A1998953119512009448308
   PubMed Web of Science ®Google Scholar
• AlexanderWSRobertsAWNicolaNALiRMetcalfDDeficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-MplBlood1996876216221708630375
   PubMed Web of Science ®Google Scholar
• KuterDJNew thrombopoietic growth factorsBlood2007109114607461617289815
   PubMed Web of Science ®Google Scholar
• KuterDJBegleyCGRecombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood2002100103457346912411315
   PubMed Web of Science ®Google Scholar
• LiJYangCXiaYThrombocytopenia caused by the development of antibodies to thrombopoietinBlood200198123241324811719360
   PubMed Web of Science ®Google Scholar
• SekeresMAKantarjianHFenauxPSubcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromesCancer20111175992100020945323
   PubMed Web of Science ®Google Scholar
• KantarjianHFenauxPSekeresMASafety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopeniaJ Clin Oncol201028343744420008626
   PubMed Web of Science ®Google Scholar
• KantarjianHMGilesFJGreenbergPLPhase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapyBlood2010116173163317020631375
   PubMed Web of Science ®Google Scholar
• BusselJBKuterDJGeorgeJNAMG 531, a thrombopoiesis-stimulating protein, for chronic ITPN Engl J Med2006355161672168117050891
   PubMed Web of Science ®Google Scholar
• KuterDJBusselJBLyonsRMEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialLancet2008371961039540318242413
   PubMed Web of Science ®Google Scholar
• KuterDJRummelMBocciaRRomiplostim or standard of care in patients with immune thrombocytopeniaN Engl J Med2010363201889189921067381
   PubMed Web of Science ®Google Scholar
• KuterDJBusselJBNewlandALong-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacyBr J Haematol2013161341142323432528
   PubMed Web of Science ®Google Scholar
• KuterDJNew thrombopoietic growth factorsClin Lymphoma Myeloma20099suppl 3S347S35619778863
   PubMedGoogle Scholar
• DengYMadatianAWireMBMetabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjectsDrug Metab Dispos20113991734174621646437
   PubMed Web of Science ®Google Scholar
• Erickson-MillerCLDelormeETianSSPreclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonistStem Cells200927242443019038790
   PubMed Web of Science ®Google Scholar
• MilosevicISladeEDrysdaleHCOMPare Project TeamEltrombopag for chronic immune thrombocytopeniaLancet20163871001633626842445
   PubMed Web of Science ®Google Scholar
• GraingerJDLocatelliFChotsampancharoenTEltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialLancet2015386100041649165826231455
   PubMed Web of Science ®Google Scholar
• González-LópezTJAlvarez-RománMTPascualCEltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceEur J Haematol2015 Epub20151228
   Web of Science ®Google Scholar
• SalehMNBusselJBChengGEXTEND Study GroupSafety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood2013121353754523169778
   PubMed Web of Science ®Google Scholar
• FontanaVJyWAhnERIncreased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITPThromb Res2008122559960318334267
   PubMed Web of Science ®Google Scholar
• AfdhalNHGianniniEGTayyabGELEVATE Study GroupEltrombopag before procedures in patients with cirrhosis and thrombocytopeniaN Engl J Med2012367871672422913681
   PubMed Web of Science ®Google Scholar
• McHutchisonJGDusheikoGShiffmanMLTPL102357 Study GroupEltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis CN Engl J Med2007357222227223618046027
   PubMed Web of Science ®Google Scholar
• UlichTRdel CastilloJSenaldiGSystemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in miceBlood19968712500650158652813
   PubMed Web of Science ®Google Scholar
• KuterDJMuftiGJBainBJHasserjianRPDavisWRutsteinMEvaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostimBlood2009114183748375619671919
   PubMed Web of Science ®Google Scholar
• VillevalJLCohen-SolalKTulliezMHigh thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in miceBlood19979011436943839373248
   PubMed Web of Science ®Google Scholar
• BrynesRKOraziATheodoreDEvaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: data from the EXTEND studyAm J Hematol201590759860125801698
   PubMed Web of Science ®Google Scholar
• TanakaTInamotoYYamashitaTEltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantationBiol Blood Marrow Transplant201622591992426785333
   PubMed Web of Science ®Google Scholar
• DesmondRTownsleyDMDumitriuBEltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood2014123121818182524345753
   PubMed Web of Science ®Google Scholar
• BusselJBde MiguelPGDespotovicJMEltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyLancet Haematol201528e315e32526688484
   PubMed Web of Science ®Google Scholar
• KillickSBWinNMarshJCPilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemiaBr J Haematol19979736776849207422
   PubMed Web of Science ®Google Scholar
• MarshJCGanserAStadlerMHematopoietic growth factors in the treatment of acquired bone marrow failure statesSemin Hematol200744313814717631178
   PubMed Web of Science ®Google Scholar
• KingSGermeshausenMStraussGWelteKBallmaierMCongenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patientsBr J Haematol2005131563664416351641
   PubMed Web of Science ®Google Scholar
• OlnesMJScheinbergPCalvoKREltrombopag and improved hematopoiesis in refractory aplastic anemiaN Engl J Med20123671111922762314
   PubMed Web of Science ®Google Scholar
• MakarRSZhukovOSSahudMAKuterDJThrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonistsAm J Hematol201388121041104423913253
   PubMed Web of Science ®Google Scholar
• MarshJCMuftiGJEltrombopag: a stem cell cookie?Blood2014123121774177524652959
   PubMed Web of Science ®Google Scholar
• BaoWBusselJBHeckSImproved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agentsBlood2010116224639464520688957
   PubMed Web of Science ®Google Scholar
• JenkinsJMWilliamsDDengYPhase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonistBlood2007109114739474117327409
   PubMed Web of Science ®Google Scholar
• BusselJBChengGSalehMNEltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraN Engl J Med2007357222237224718046028
   PubMed Web of Science ®Google Scholar
• ChengGSalehMMarcherCEltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomized phase 3 studyLancet2011377976339340220739054
   PubMed Web of Science ®Google Scholar
• PlatzbeckerUWongRSVermaASafety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialLancet Haematol2015210e417e42626686043
   PubMed Web of Science ®Google Scholar